Skip to main content

Table 1 Recipient and donor characteristics

From: Effect of targeted coagulopathy management and 5% albumin as volume replacement therapy during lung transplantation on allograft function: a secondary analysis of a randomized clinical trial

Recipient characteristics variable

non-POC group (n = 36)

POC group (n = 31)

p-value

Male sex

25 (69%)

20 (64.5%)

0.67

Age (years; mean ± SD)

56.22 ± 9.05

45.69 ± 16.54

0.002

Weight (kg; mean ± SD)

76.64 ± 18.21

67.48 ± 16.51

0.036

Height (cm; mean ± SD)

173.81 ± 9.72

169.55 ± 9.57

0.08

Body mass index (mean ± SD)

25.03 ± 4.04

23.25 ± 4.33

0.09

MPAP (mmHg; mean ± SD)

23.97 ± 6.05

25.58 ± 9.63

0.43

Transplant indication

 COPD

15 (41.6%)

12 (38.7%)

0.81

 Pulmonary fibrosis

18 (50%)

9 (29%)

0.08

 Cystic fibrosis

2 (5.6%)

10 (32.3%)

0.005

 Sarcoidosis

1 (2.8%)

0

0.35

Intra-Operative recipient characteristics

 Thoracotomy

  Sternum sparing

5 (14%)

8 (25.8%)

0.22

  Clamshell

31 (86%)

23 (74.2%)

0.22

  Intraoperative ECMO

31 (86%)

21 (67.7%)

0.07

Ischemic time (min; mean ± SD)

 First lung

242.83 ± 40.23

243.52 ± 40.96

0.91

 Second lung

353.69 ± 47.21

354.06 ± 58.02

0.24

Donor characteristics variable

non-POC group (n = 36)

POC group (n = 31)

p-value

Male sex

23 (63.9%)

17 (54.8%)

0.45

Age (years; mean ± SD)

43.56 ± 18.84

43.81 ± 15.14

0.95

Weight (kg; mean ± SD)

71.67 ± 16.32

73.77 ± 18.12

0.62

Height (cm; mean ± SD)

170.92 ± 12.98

173.81 ± 9.95

0.32

Body mass index (mean ± SD)

25.13 ± 6.71

24.28 ± 5.26

0.57

Horowitz index (mmHg; mean ± SD)

468.56 ± 64.58

475.32 ± 63.83

0.67

Smoking history, n (%)

8 (22.2%)

5 (16.1%)

0.53

Cause of death, n (%)

 subarachnoid hemorrhage

5 (13.9%)

7 (22.6%)

0.35

 intracerebral bleeding

9 (25%)

9 (29%)

0.71

 trauma capitis

13 (36.1%)

11 (35.5%)

0.96

 anoxic brain damage

7 (19.4%)

1(3.2%)

0.06

 other

2 (5.6%)

3 (9.7%)

0.66

  1. Abbreviations: COPD chronic obstructive pulmonary disease, ECMO extracorporeal membrane oxygenation, MPAP mean pulmonary arterial pressure, POC point of care, SD standard deviation. Previously published in Durila M, Vajter J, Garaj M, Pollert L, Berousek J, Vachtenheim J, Jr., et al. Rotational thromboelastometry reduces blood loss and blood product usage after lung transplantation. J Heart Lung Transplant. 2021;40(7):631–41.18